EdgarLookup

Ocean Biomedical, Inc. — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Ocean Biomedical, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q1 2025 Mar 31, 2025 ($8.24M) May 15, 2025
Q3 2024 Sep 30, 2024 ($5.53M) Jan 13, 2025
Q2 2024 Jun 30, 2024 ($17.23M) Dec 23, 2024
Q1 2025 Mar 31, 2024 $13.00M May 15, 2025
Q3 2024 Sep 30, 2023 ($14.09M) Jan 13, 2025
Q2 2024 Jun 30, 2023 ($11.43M) Dec 23, 2024
Q1 2024 Mar 31, 2023 ($72.09M) Dec 23, 2024
Q3 2023 Sep 30, 2022 ($3.67M) Apr 15, 2024
Q3 2022 Jun 30, 2022 ($184.9K) Oct 17, 2022
Q2 2023 Jun 30, 2022 ($7.33M) Apr 15, 2024
Q3 2022 Mar 31, 2022 ($165.7K) Oct 17, 2022
Q1 2023 Mar 31, 2022 ($5.38M) Apr 15, 2024
Q2 2022 Mar 31, 2022 ($165.7K) Jul 11, 2022
Q3 2022 Sep 30, 2021 ($42.5K) Oct 17, 2022
Q2 2022 Jun 30, 2021 ($82) Jul 11, 2022
Q3 2022 Jun 30, 2021 ($82) Oct 17, 2022

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q1 2025 Mar 31, 2025 ($958.0K) May 15, 2025
Q3 2024 Sep 30, 2024 ($768.0K) Jan 13, 2025
Q2 2024 Jun 30, 2024 ($682.0K) Dec 23, 2024
Q1 2025 Mar 31, 2024 ($595.0K) May 15, 2025
Q3 2024 Sep 30, 2023 ($2.66M) Jan 13, 2025
Q2 2024 Jun 30, 2023 ($2.83M) Dec 23, 2024
Q1 2024 Mar 31, 2023 ($5.39M) Dec 23, 2024
Q3 2023 Sep 30, 2022 ($3.17M) Apr 15, 2024
Q2 2023 Jun 30, 2022 ($6.90M) Apr 15, 2024
Q1 2023 Mar 31, 2022 ($5.11M) Apr 15, 2024
Q3 2022 Sep 30, 2021 ($42.7K) Oct 17, 2022
Q2 2022 Jun 30, 2021 ($82) Jul 11, 2022